PubMed · 2005 · 39 citations · 29 references
Life SciencesGeneticsMolecular GeneticsCancer GeneticsHuman GeneticsMedical GeneticsBreast Cancer Risk AssessmentCancer RiskFolate DeficiencyGenetic Risk AssessmentGenotype-phenotype Association AnalysisFolate Metabolism GeneticsGenetic Predisposition To CancerHereditary Cancer RiskInherited Cancer SusceptibilityMethylenetetrahydrofolate Reductase PolymorphismsSingle-nucleotide Polymorphism Risk AnalysisSingle-nucleotide Polymorphisms
BACKGROUND: Folate deficiency is implicated in cancer development. Single nucleotide polymorphisms in the methylenetetrahydrofolate reductase (MTHFR) gene can modulate the effect of folate. In this case-controlled study, a possible effect of the common MTHFR C677T (ala-->val) polymorphism on breast cancer susceptibility in Turkish patients was investigated. MATERIALS AND METHODS: Polymorphism analysis was performed by melting curve analysis. RESULTS: The variant allele valine (677T) was more frequent among the patients (30.1%) than in controls (23.9%). This difference was weakly significant (p = 0.046; OR = 1.37) and due to a significantly higher frequency of the valine homozygotes (677TT) among the patients (12.1% vs. 5.4%; p = 0.013, OR = 2.5). Among the patients diagnosed at more than 40 years of age, a more pronounced association of the valine homozygotes with breast cancer risk was observed (p = 0.009; OR = 3.3). CONCLUSION: Homozygosity for the low-activity C677T genotype (TT) may represent a genetic determinant increasing breast cancer risk.
29
Christine F. Skibola, Martyn T. Smith, Eleanor Kane et al. · Proceedings of the National Academy of Sciences · 1999 · 530 citations · Full text
A methylenetetrahydrofolate reductase polymorphism and the risk of colorectal cancer.
J. Chen, Edward L. Giovannucci, Karl T. Kelsey et al. · PubMed · 1996 · 520 citations
Joseph L. Wiemels, R. Smith, G. Malcolm Taylor et al. · Proceedings of the National Academy of Sciences · 2001 · 339 citations · Full text